[1] |
CHEN Siyu, PAN Bin, LEI Xin, et al.
Risk factors for early hypocalcemia after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(3): 214-219.
|
[2] |
YANG Xi, DONG Jianhua, WU Bian, FAN Wenjing, HUANG Li, LI Chuan, GE Yongchun.
The observational study of paricalcitol combine with cinacalcet in treatment of hemodialysis patients with refractory secondary hyperparathyroidism
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(6): 514-518.
|
[3] |
CHENG Ming, HUANG Bihong, TAO Ye, FAN Chunyan, WANG Mengjing, WANG Hongying, ZHANG Minmin.
Uremic patients with secondary hyperparathyroidism after parathyroidectomy: a prospective cohort study
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(3): 231-237.
|
[4] |
.
Persistent low circulating parathyroid hormone levels after parathyroidectomy for secondary hyperparathyroidism patients with chronic kidney disease
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(4): 368-373.
|
[5] |
XU Jinmei,LIN Jingjing,CHEN Siyu,LEI Xin,JIANG Hua,CHEN Jianghua,ZHANG Ping.
Predictive value of intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2020, 29(6): 514-519.
|
[6] |
CHEN Xueqin,LI Bohou,ZHANG Fengxia,LIAN Zhiwen,JIANG Nan,WEN Sichun,WU Qiong,XIA Yubin,KE Guibao,ZHANG Hong,KUANG Sujuan,DENG Chunyu,LIU Shuangxin.
Mechanisms of COMMD5 participates in hypotensive effect after parathyroidectomy in hemodialysis patients
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2020, 29(6): 520-525.
|
[7] |
ACTIVE work group.
Rationale and design of cinacalcet in Chinese maintenance hemodialysis patients with secondary hyperparathyroidism (ACTIVE) study:A phase Ⅳ,multicenter,openlabel study ACTIVE work group
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2020, 29(5): 478-483.
|
[8] |
ZHAO Shasha,WEN Ping,GAN Wei,et al.
Complications after parathyroidectomy for secondary hyperparathyroidism
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2019, 28(1): 19-23.
|
[9] |
ZHANG Rui,ZHANG Nianrong,XI Qiuping,et al.
Abdominal aortic calcification in maintenance hemodialysis patients with refractory secondary hyperparathyroidism
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2017, 26(5): 432-437.
|
[10] |
MA Haoyang,CHENG Chen,WANG Ningning,et al.
Thermal ablation in the management of severe secondary hyperparathyroidism
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2017, 26(4): 370-375.
|
[11] |
WANG Wei,LI Guisen,WANG Li.
Treatment of secondary hyperparathyroidism in hemodialysis patients with active vitamin D and its analogue—guidelines review
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2017, 26(4): 381-385.
|
[12] |
ZHANG Lina,JIANG Yao,CHENG Chen,et al.
Impact of parathyroidectomy on plasma fibroblast growth factor 23 levels and heart rate variability in chronic kidney disease patients
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2016, 25(1): 40-45.
|
[13] |
Sun Haiyong|Wang Tiantian|Li Hongyue|et al.
Surgical treatment of secondary hyperparathyroidism in patients with chronic renal failure
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2015, 24(4): 337-341.
|
[14] |
WANG Taina|XU Bin|JIA Fengyu|et al.
Treatment of secondary hyperparathyroidism in hemodilysis patients by paricalcitol with a medium initial dosage: a prospective observational study
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2015, 24(1): 1-5.
|
[15] |
TANG Xueqin| CHEN Zejun| GAN Hua.
Meta analysis of pulse alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2014, 23(2): 128-135.
|